Drug intelligence / Profile preview

XingpiJieyu Formula

Development stage
Unknown
Lead developer
Peking University Sixth Hospital
Modality
Small Molecules
Administration
Oral
01

Overview

XingpiJieyu Formula (XPJYF) is a traditional Chinese medicine (TCM) botanical compound developed by researchers at Peking University Sixth Hospital for the treatment of major depressive disorder (MDD). It is specifically indicated for patients presenting with the TCM syndrome of liver depression and spleen deficiency. The formula is composed of four primary herbal ingredients: *Panax quinquefolius* (American ginseng), *Acorus tatarinowii*, *Curcuma longa L.* (turmeric), and *Hypericum perforatum L.* (St. John's wort). XPJYF is thought to exert its antidepressant effects through multiple pathways, including modulation of the gut microbiota-brain axis, activation of the cAMP-PKA-CREB-BDNF signaling pathway, and regulation of neurotransmitter systems. Clinical studies have evaluated its efficacy both as a monotherapy for mild-to-moderate depression and as an adjunctive therapy with SSRIs like escitalopram for moderate-to-severe MDD.

Other names
XingpiJieyu decoction
02

Targets

PKA (Cyclic amp-dependent protein kinase)CREB (Cyclic AMP response element-binding protein)BDNF (Brain-derived neurotrophic factor)

Beyond the preview

Go deeper on XingpiJieyu Formula.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on XingpiJieyu Formula.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call